Psychiatry & Neurology Doctors in Slidell, LA Accepting Medicare

7 Psychiatry & Neurology doctors found. Showing 1 - 7

Dr. Richard F. Kutner, M.D. Psychiatry & Neurology - Child & Adolescent Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 113 Christian Ln, Slidell, LA 70458 Phone: 985-781-7353    Fax: 985-781-7354

Balminder S Mangat, MD Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 1924 Corporate Square Dr Ste C, Slidell, LA 70458 Phone: 985-649-2576    Fax: 985-735-9105

Dr. Maria De Los Angeles Pons, M.D. Psychiatry & Neurology - Neurology with Special Qualifications in Child Neurology Medicare: Not Enrolled in Medicare Practice Location: 105 Medical Center Dr, Suite 306, Slidell, LA 70461 Phone: 985-643-3033    Fax: 985-643-3099

James B Denney, MD Psychiatry & Neurology - Forensic Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 609 Brownswitch Rd, Slidell, LA 70458 Phone: 985-641-5330    Fax: 985-641-6589

Anwantbir Chawla, MD Psychiatry & Neurology - Psychiatry Medicare: Medicare Enrolled Practice Location: 104 Smart Pl, Slidell, LA 70458 Phone: 985-774-6377    Fax: 985-726-5158

Janet Seligson-dowie, M.D. Psychiatry & Neurology - Psychiatry Medicare: Medicare Enrolled Practice Location: 2750 E Gause Blvd, Slidell, LA 70461 Phone: 985-639-3777

Bartholomew Eric Jackson Sr., NURSE PRACTITIONER Psychiatry & Neurology - Psychiatry Medicare: Medicare Enrolled Practice Location: 7861 Camellia Bud Ct, Slidell, LA 70461 Phone: 315-281-6945

News Archive

BRI partners with French Government to create therapeutic antibodies for treatment of major diseases

"We are delighted to be working with such esteemed institutions in order to generate cutting-edge therapeutic antibodies," said Matthew Baker, chief scientific officer and co-founder of Antitope. "This agreement combines our partners' expertise in novel therapeutic strategies with Antitope's expertise in engineering humanized antibodies to create therapeutic antibodies that may have a significant impact on the treatment of these major diseases."

Pfizer's Prevenar 13 granted European marketing authorization

The European Commission has granted Pfizer Inc. a European marketing authorization for its pneumococcal conjugate vaccine, Prevenar 13 (Pneumococcal Polysaccharide Conjugate Vaccine [13-valent, adsorbed]). Prevenar 13 is indicated for active immunization for the prevention of invasive disease, pneumonia, and acute otitis media caused by 13 Streptococcus pneumoniae serotypes in infants and children from 6 weeks to 5 years of age. Invasive pneumococcal disease includes sepsis, meningitis, bacteremia, bacteremic pneumonia, and empyema.

Pharmacy technician certification associated with reduction in medication errors, survey finds

Results from a recent Pharmacy Technician Certification Board sponsored survey find that lead pharmacists perceive pharmacy technician certification as an essential component in reducing medication errors, ensuring patient safety, and increasing positive health outcomes. The results, unveiled at the American Pharmacists Association Annual Meeting in March 2010 by researcher Shane Desselle, R.Ph., PhD, FAPhA, Associate Dean for Tulsa Programs, Chair, and Professor of the Department of Pharmacy: Clinical and Administrative Sciences at University of Oklahoma College of Pharmacy, were gathered from a random sample of over 3,250 pharmacists serving in a variety of practice settings across the United States.

Good News Care Center launches ER Diversion Program for South Florida Hospitals

The Good News Care Center has launched their ER Diversion Program to provide relief for over populated emergency rooms in main South Florida Hospitals. The program is held initially in accordance with Homestead and Baptist Hospitals.

Read more Medical News

› Verified 1 days ago